JURIDICAL FOUNDATION THE CHEMO SERO THERAPEUTIC RES INSTITUTE has a total of 20 patent applications. Its first patent ever was published in 1996. It filed its patents most often in Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are NIPPI INCORPORATED, CELL & BIO CO LTD and HALL FREDERICK L.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 20 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines | |
#4 | Measurement | |
#5 | Medical technology | |
#6 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Enzymes | |
#6 | Unspecified technologies | |
#7 | Analysing materials | |
#8 | Object sterilising | |
#9 | Measuring microorganism processes | |
#10 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Nozaki Chikateru | 9 |
#2 | Maeda Hiroaki | 6 |
#3 | Nakashima Toshihiro | 4 |
#4 | Soejima Kenji | 4 |
#5 | Hirashima Masaki | 4 |
#6 | Sugimura Kazuhisa | 3 |
#7 | Sasaki Takumi | 3 |
#8 | Imamura Takayuki | 3 |
#9 | Hamamoto Takayoshi | 3 |
#10 | Mimura Noriko | 3 |
Publication | Filing date | Title |
---|---|---|
AU2012207034A1 | Von Willebrand factor (vWF) - cleaving protease | |
AU2008202376A1 | Process for producing human thrombin by gene modification technique | |
AU2007242956A1 | Novel agents for ameliorating motor disorder | |
AU2006260184A1 | Prophylactic or therapeutic agent for corneal/conjunctival disease | |
AU2003262051A1 | Human antihuman MCP-1 antibody and antibody fragment thereof |